Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan · Delayed Price · Currency is TWD 75.00
-2.40 (-3.10%)
Feb 11, 2026, 1:30 PM CST
Handa Pharmaceuticals Market Cap
Handa Pharmaceuticals has a market cap or net worth of 11.8 billion as of February 13, 2026. Its market cap has increased by 17.37% in one year.
Market Cap
11.80B
Enterprise Value
9.23B
Revenue
1.62B
Ranking
n/a
PE Ratio
16.55
Stock Price
75.00
Market Cap Chart
Since December 28, 2016, Handa Pharmaceuticals's market cap has increased from 8.32B to 11.80B, an increase of 41.84%. That is a compound annual growth rate of 3.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 11.80B | -12.79% |
| Dec 31, 2025 | 13.53B | 27.93% |
| Dec 31, 2024 | 10.58B | -59.15% |
| Dec 29, 2023 | 25.89B | 61.07% |
| Dec 30, 2022 | 16.07B | 90.20% |
| Dec 30, 2021 | 8.45B | 199.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TTY Biopharm Company | 20.91B |
| Grape King Bio | 18.15B |
| Alar Pharmaceuticals | 17.57B |
| ScinoPharm Taiwan | 17.36B |
| Synmosa Biopharma | 16.25B |
| YungShin Global Holding | 14.70B |
| Foresee Pharmaceuticals | 13.47B |
| Standard Chemical & Pharmaceutical | 10.86B |